SOMNF (SomnoMed) Tax Provision : $-1.13 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Tax Provision?

SomnoMed's tax provision for the six months ended in Dec. 2024 was $-1.02 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2024 was $-1.13 Mil.

SomnoMed Tax Provision Historical Data

The historical data trend for SomnoMed's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Tax Provision Chart

SomnoMed Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Tax Provision

Get a 7-Day Free Trial

-0.82

-0.27

-0.65

-0.55

-0.65

SomnoMed Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Tax Provision	Get a 7-Day Free Trial															-0.56	-	-0.54	-0.11	-1.02

SomnoMed Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.13 Mil.

SomnoMed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

RJV:Germany SOM:Australia

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.